Brian Beeman, MD
Vascular Surgery · Urbana, ILNPI 1033384722
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 37.2% of the total. 2025 is the largest year on record at $11,226, 4.2 times the $2,697 reported in 2019.
Across 120 payments — averaging $163.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- W. L. Gore & Associates, Inc.$6K
- Lemaitre Vascular, Inc.$3K
- Bolton Medical Inc$1K
- Abbott$1K
- Penumbra, Inc.$381
- plus $1K from 11 others
Across 8 payments — averaging $3007.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$20K
- Boston Scientific$4K
What the payments were for
- Consulting fees$1,8099%
- Travel & lodging$10,16652%
- Food & beverage$7,17537%
- Education$4282%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 29 | $7,282 |
| W. L. Gore & Associates, Inc. | 54 | $5,606 |
| Lemaitre Vascular, Inc. | 6 | $2,512 |
| Bolton Medical Inc | 9 | $1,415 |
| Abbott | 5 | $1,042 |
| Penumbra, Inc. | 3 | $381 |
| Silk Road Medical, Inc. | 3 | $327 |
| Shockwave Medical, Inc | 2 | $215 |
| Edwards Lifesciences | 1 | $153 |
| Johnson & Johnson | 1 | $139 |
| Endologix LLC | 1 | $116 |
| Boston Scientific | 1 | $111 |
| Acera Surgical, Inc. | 1 | $98 |
| Philips North America LLC | 1 | $73 |
| Integra Lifesciences Corporation | 1 | $62 |
| Stryker | 1 | $27 |
| Organogenesis Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$5,727
- ARTEGRAFT VASCULAR GRAFT$1,809
- GORE TAG Conformable Thoracic Stent Graft$1,197
- Xience V coronary stent system$745
- TREO ABDOMINAL STENT-GRAFT SYSTEM$676
- GORE VIABAHN VBX Balloon Expandable Endo$598
- HYDRO LEMAITRE VALVULOTOME$590
- GORE-TEX Vascular Graft$412
- ENROUTE Transcarotid Neuroprotection System$324
- ENROUTE Transcarotid Stent System$324
- ENHANCE Transcarotid Peripheral Access Kit$324
- ENROUTE 0.014 Guidewire$324
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$301
- C3 Delivery System$301
- ENDURANT IIS$274
- VIABAHN VBX Balloon Expandable Endoprosthesis$257
- Penumbra System$253
- Conformable TAG Thoracic Endoprosthesis$199
- Vascular Graft$175
- GORE TAG Thoracic Branch Endoprosthesis$174
How this compares
$19,578 in reported general payments places this provider in the 80th percentile of 170 vascular surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 30 | $25,443 |
| Cilostazol | 35 | $1,004 |
| ClopidogrelClopidogrel Bisulfate | 68 | $761 |
| Warfarin Sodium | 35 | $665 |
| Atorvastatin Calcium | 11 | $265 |
| Gabapentin | 20 | $149 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $139 | $25,44330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 170 vascular surgery providers in Illinois.
Other vascular surgery in Urbana
- Mahmoud ElrakhawyUrbana$18K
- Ross MilnerChicago$1.3M
- Sapan DesaiArlington Heights$1.2M
- Nabeel RanaPeoria$934K
- Atif BaqaiPark Ridge$567K
- Trissa BabrowskiChicago$292K
- Tejas ShahDowners Grove$213K
- Carlos BecharaMaywood$199K
- Dhiren PatelSpringfield$121K
- Heron RodriguezChicago$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.